Molina Healthcare (NYSE:MOH) Price Target Raised to $250.00

Molina Healthcare (NYSE:MOH) had its target price upped by Truist Financial from $205.00 to $250.00 in a report published on Tuesday morning, Marketbeat Ratings reports. They currently have a hold rating on the stock.

Several other analysts have also weighed in on MOH. Barclays lowered their target price on Molina Healthcare from $199.00 to $184.00 and set an “underweight” rating on the stock in a report on Wednesday, July 8th. TD Cowen boosted their price objective on shares of Molina Healthcare from $163.00 to $230.00 and gave the stock a “hold” rating in a research report on Tuesday. Weiss Ratings raised shares of Molina Healthcare from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, June 25th. Bank of America upgraded shares of Molina Healthcare from an “underperform” rating to a “buy” rating and set a $250.00 target price for the company in a report on Wednesday, April 29th. Finally, Robert W. Baird lifted their target price on shares of Molina Healthcare from $124.00 to $163.00 and gave the stock a “neutral” rating in a research report on Monday, May 11th. Three equities research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, Molina Healthcare currently has an average rating of “Hold” and an average target price of $207.06.

Molina Healthcare Trading Down 3.6%

NYSE:MOH opened at $225.05 on Tuesday. Molina Healthcare has a 1 year low of $121.06 and a 1 year high of $244.89. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.63 and a current ratio of 1.63. The stock has a fifty day moving average price of $202.64 and a two-hundred day moving average price of $175.16. The stock has a market capitalization of $11.72 billion, a price-to-earnings ratio of 66.58 and a beta of 0.74.

Molina Healthcare (NYSE:MOH) last issued its earnings results on Wednesday, April 22nd. The company reported $2.35 EPS for the quarter, topping the consensus estimate of $1.57 by $0.78. Molina Healthcare had a net margin of 0.42% and a return on equity of 8.76%. The company had revenue of $10.80 billion for the quarter, compared to analyst estimates of $10.91 billion. During the same period in the previous year, the firm earned $6.08 EPS. The business’s revenue was down 3.1% on a year-over-year basis. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts anticipate that Molina Healthcare will post 5.23 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In related news, insider Jeff D. Barlow sold 17,811 shares of the stock in a transaction on Monday, May 11th. The stock was sold at an average price of $186.12, for a total transaction of $3,314,983.32. Following the sale, the insider owned 67,175 shares of the company’s stock, valued at $12,502,611. This trade represents a 20.96% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Maurice Hebert sold 600 shares of Molina Healthcare stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $191.55, for a total value of $114,930.00. Following the sale, the chief accounting officer owned 12,815 shares of the company’s stock, valued at approximately $2,454,713.25. This represents a 4.47% decrease in their position. The SEC filing for this sale provides additional information. 1.44% of the stock is owned by corporate insiders.

Institutional Trading of Molina Healthcare

A number of hedge funds have recently added to or reduced their stakes in MOH. Baird Financial Group Inc. purchased a new stake in Molina Healthcare in the first quarter valued at approximately $210,000. NewEdge Advisors LLC boosted its holdings in shares of Molina Healthcare by 33.4% in the 1st quarter. NewEdge Advisors LLC now owns 1,106 shares of the company’s stock valued at $364,000 after purchasing an additional 277 shares during the last quarter. Jones Financial Companies Lllp boosted its holdings in shares of Molina Healthcare by 713.3% in the 1st quarter. Jones Financial Companies Lllp now owns 1,651 shares of the company’s stock valued at $544,000 after purchasing an additional 1,448 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in shares of Molina Healthcare by 19.4% during the 1st quarter. Goldman Sachs Group Inc. now owns 249,466 shares of the company’s stock valued at $82,172,000 after buying an additional 40,531 shares during the period. Finally, Woodline Partners LP purchased a new stake in shares of Molina Healthcare during the 1st quarter valued at $1,541,000. 98.50% of the stock is owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.